Serum Antioxidant Capacity and the Risk of Contrast Medium Nephropathy

Publisher： Karger

E-ISSN： 1660-2110|99|1|c13-c17

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.99, Iss.1, 2005-01, pp. : c13-c17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin-Converting Enzyme Inhibitors as a Risk Factor for Contrast-Induced Nephropathy

By  

Nephron Clin Pract, Vol. 104, Iss. 1, 2006-05 ,pp. : c20-c27

Karger

Access to resources Recommend Favorite

Novel risk score of contrast‐induced nephropathy after percutaneous coronary intervention

By  

NEPHROLOGY, Vol. 20, Iss. 8, 2015-08 ,pp. : 544-551

John Wiley & Sons Inc

Access to resources Recommend Favorite

Contrast-Induced Nephropathy in Percutaneous Coronary Interventions: Pathogenesis, Risk Factors, Outcome, Prevention and Treatment

By  

Cardiology, Vol. 128, Iss. 1, 2014-02 ,pp. : 62-72

Karger

Access to resources Recommend Favorite

Acute effect of ionic high osmolar contrast medium on renal antioxidant enzyme activity in streptozotocin-induced diabetic rats

By Yen H.-W.   Lee H.-C.   Chuang H.-Y.   Lai W.-T.   Sheu S.-H.  

Clinical and Experimental Medicine, Vol. 6, Iss. 2, 2006-06 ,pp. : 94-98

Springer Publishing Company

Access to resources Recommend Favorite

AVERTing contrast nephropathy—delivering less to get more?

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 7, 2015-12 ,pp. : 1234-1235

John Wiley & Sons Inc

Access to resources Recommend Favorite